![Raul Rodriguez](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Raul Rodriguez
Vorstandsvorsitzender bei
RIGEL PHARMACEUTICALS, INC.
Vermögen: 9 Mio $ am 31.05.2026
Profil
Raul R.
Rodriguez is currently President, Chief Executive Officer & Director at Rigel Pharmaceuticals, Inc. since 2014, with employment at the company starting in 2000.
Formerly, Mr. Rodriguez was Executive Director-Business Development at Scios, Inc. from 1994 to 1997 and Senior VP-Business Development & Operations at Ontogeny, Inc. from 1997 to 2000.
Education includes graduate studies at the University of Illinois, an MBA from Stanford Graduate School of Business, and undergraduate studies at Harvard College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 17.06.2026 | 279.593 ( 1,51 % ) | 9 Mio $ | 31.05.2026 |
Aktive Positionen von Raul Rodriguez
| Unternehmen | Position | Beginn |
|---|---|---|
| RIGEL PHARMACEUTICALS, INC. | Vorstandsvorsitzender | 21.11.2014 |
Ehemalige bekannte Positionen von Raul Rodriguez
| Unternehmen | Position | Ende |
|---|---|---|
Ontogeny, Inc.
 Ontogeny, Inc. BiotechnologyHealth Technology Develops therapeutics for neurological diseases | Geschäftsführer | 01.03.2000 |
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures & commercializes pharmaceuticals | Corporate Officer/Principal | 01.03.1997 |
Ausbildung von Raul Rodriguez
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
40
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures & commercializes pharmaceuticals | Health Technology |
Rigel Pharmaceuticals, Inc.
 Rigel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which discovers, develops and provides novel small-molecule drugs | Health Technology |
Ontogeny, Inc.
Ontogeny, Inc. BiotechnologyHealth Technology Develops therapeutics for neurological diseases | Health Technology |
University of Illinois
 University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford Graduate School of Business
 Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wählen Sie MarketScreener 
